Skip to main content
SpringerLink
Log in

Adjunctive and Integrative Therapy in Migraine Management

  • Chapter
  • First Online:
Sinus Headache, Migraine, and the Otolaryngologist

  • 805 Accesses

Abstract

Patients have long combined complementary practices with more conventional Western medicine. Contrary to popular belief by many in the medical community, there is substantial evidence that certain types of complementary therapies are effective for migraine. Studies have shown that Petasites, acupuncture, relaxation training, biofeedback, and cognitive behavior therapy have been established with Class A evidence of effectiveness for treating migraine headache. Magnesium, feverfew, riboflavin, and exercise have been shown to probably be effective, while Co-Q10, phytoestrogens, chiropractic therapies, massage, hyperbaric oxygen therapy, and hypnotherapy have been shown to be possibly effective. Use of these therapies alone, or combined with conventional therapies has yielded good results for many patients. This chapter will review integrative medicine and the evidence to support its use in migraine headache.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. (NCCIH). Use of complementary health approaches in the U.S. National Health Interview Survey (NHIS). 9000 Rockville Pike, Bethesda, Maryland 208922015 (Available from: https://nccih.nih.gov/research/statistics/NHIS/2012/about).

  2. (NCCIH). Complementary, alternative, or integrative health: what’s in a name? 9000 Rockville Pike, Bethesda, Maryland 208922016 (Available from: https://nccih.nih.gov/health/integrative-health-cvsa).

  3. (NCCIH). Frequently asked questions: name change 2014 (Available from: https://nccih.nih.gov/news/name-change-faq).

  4. Physician Specialities ABo. American board of integrative medicine 2016 (available at http://www.abpsus.org/integrative-medicine).

  5. Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087–97.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sun-Edelstein C, Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache. 2011;51(3):469–83.

    Article  PubMed  Google Scholar 

  7. French J, Gronseth G. Lost in a jungle of evidence: we need a compass. Neurology. 2008;71(20):1634–8.

    Article  PubMed  Google Scholar 

  8. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.

    Article  CAS  PubMed  Google Scholar 

  9. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1346–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Campbell JK, Penzien D, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. Am Acad Neurol. 1998 (Available from: http://tools.aan.com/professionals/practice/pdfs/gl0089.pdf).

  11. Prieto J. Update on the efficacy and safety of Petadolex, a butterbur extract for migraine prophylaxis. Botanics Targets Ther. 2014;2:1–9.

    Article  Google Scholar 

  12. Wang GJSA, Lin YL, et al. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasine, a hypotensive sesquiterpene from Petasites formosanus. J Pharmacol Exp Ther. 2001;297(1):240–6.

    CAS  PubMed  Google Scholar 

  13. Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol. 2004;51(2):89–97.

    Article  CAS  PubMed  Google Scholar 

  14. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–4.

    Article  CAS  PubMed  Google Scholar 

  15. Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther. 2000;38(9):430–5.

    Article  CAS  PubMed  Google Scholar 

  16. Oelkers-Ax R, Leins A, Parzer P, Hillecke T, Bolay HV, Fischer J, et al. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain. 2008;12(3):301–13.

    Article  PubMed  Google Scholar 

  17. Sutherland A, Sweet BV. Butterbur: an alternative therapy for migraine prevention. Am J Health-Syst Pharm: AJHP: Official J Am Soc Health-Syst Pharmacists. 2010;67(9):705–11.

    Article  CAS  Google Scholar 

  18. Mauskop A. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2013;80(9):868.

    Article  PubMed  Google Scholar 

  19. Daniel O, Mauskop A. Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol. 2016;18(4):14.

    Article  PubMed  Google Scholar 

  20. Tepper SJ. Nutraceutical and other modalities for the treatment of headache. Continuum (Minneapolis, Minn). 2015;21(4 Headache):1018–31.

    Google Scholar 

  21. Goadsby PJ, Lipton RB, Ferrari MD. Migraine–current understanding and treatment. N Engl J Med. 2002;346(4):257–70.

    Article  CAS  PubMed  Google Scholar 

  22. Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9(3):369–79.

    Article  CAS  PubMed  Google Scholar 

  23. Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res. 2001;14(4):283–90.

    CAS  PubMed  Google Scholar 

  24. Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia. 1991;11(2):97–9.

    Article  CAS  PubMed  Google Scholar 

  25. Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia. 1993;13(2):94–81; discussion 73.

    Google Scholar 

  26. Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache. 1992;32(3):132–5.

    Article  CAS  PubMed  Google Scholar 

  27. Ramadan NM, Halvorson H, Vandelinde A, Levine SR, Helpern JA, Welch KMA. Low brain magnesium in migraine. Headache. 1989;29(9):590–3.

    Article  CAS  PubMed  Google Scholar 

  28. Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002;42(4):242–8.

    Article  PubMed  Google Scholar 

  29. Soriani S, Arnaldi C, De Carlo L, Arcudi D, Mazzotta D, Battistella PA, et al. Serum and red blood cell magnesium levels in juvenile migraine patients. Headache. 1995;35(1):14–6.

    Article  CAS  PubMed  Google Scholar 

  30. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium-sulfate relieves migraine attacks in patients with low serum ionized magnesium levels—a pilot-study. Clin Sci. 1995;89(6):633–6.

    Article  CAS  PubMed  Google Scholar 

  31. Choi H, Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med. 2014;21(1):2–9.

    PubMed  Google Scholar 

  32. Teigen L, Boes CJ. An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia. 2015;35(10):912–22.

    Article  PubMed  Google Scholar 

  33. Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology. 1994;44(4):666–9.

    Article  CAS  PubMed  Google Scholar 

  34. Shaik MM, Gan SH. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed Res Int. 2015;2015:469529.

    PubMed  PubMed Central  Google Scholar 

  35. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis—a randomized controlled trial. Neurology. 1998;50(2):466–70.

    Article  CAS  PubMed  Google Scholar 

  36. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–90.

    Article  PubMed  Google Scholar 

  37. Di Lorenzo C, Pierelli F, Coppola G, Grieco GS, Rengo C, Ciccolella M, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009;72(18):1588–94.

    Article  PubMed  Google Scholar 

  38. Sandor PS, Afra J, Ambrosini A, Schoenen J. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache. 2000;40(1):30–5.

    Article  CAS  PubMed  Google Scholar 

  39. Pringsheim T, Davenport WJ, Mackie G, Worthington I, Aube M, Christie SN, et al. Canadian headache society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2):S1–2.

    PubMed  Google Scholar 

  40. Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2015;4:CD002286.

    Google Scholar 

  41. Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr. 2000;3(4A):509–14.

    Article  CAS  PubMed  Google Scholar 

  42. Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004;1:CD002286.

    Google Scholar 

  43. Pfaffenrath V, Diener HC, Fischer M, Friede M. Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis—a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia. 2002;22(7):523–32.

    Article  CAS  PubMed  Google Scholar 

  44. Diener HC, Pfaffenrath V, Schnitker J, Friede M. Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia. 2005;25(11):1031–41.

    Article  CAS  PubMed  Google Scholar 

  45. Hershey AD, Powers SW, Vockell A-LB, LeCates SL, Ellinor PL, Segers A, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47(1):73–80.

    Article  PubMed  Google Scholar 

  46. Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011;31(8):897–905.

    Article  PubMed  Google Scholar 

  47. Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22(2):137–41.

    Article  CAS  PubMed  Google Scholar 

  48. Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–5.

    Article  CAS  PubMed  Google Scholar 

  49. Peres MF. Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia. 2005;25(6):403–11.

    Article  CAS  PubMed  Google Scholar 

  50. Peres MF, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla-Neto J. Melatonin, 3 mg, is effective for migraine prevention. Neurology. 2004;63(4):757.

    Article  CAS  PubMed  Google Scholar 

  51. Murch SJ, Simmons CB, Saxena PK. Melatonin in feverfew and other medicinal plants. Lancet. 1997;350(9091):1598–9.

    Article  CAS  PubMed  Google Scholar 

  52. Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SI. Prophylaxis of migraine with melatonin: a randomized controlled trial. Neurology. 2010;75(17):1527–32.

    Article  CAS  PubMed  Google Scholar 

  53. Goncalves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016.

    Google Scholar 

  54. Menon S, Lea RA, Roy B, Hanna M, Wee S, Haupt LM, et al. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics. 2012;22(10):741–9.

    Article  CAS  PubMed  Google Scholar 

  55. Menon S, Lea RA, Ingle S, Sutherland M, Wee S, Haupt LM, et al. Effects of dietary folate intake on migraine disability and frequency. Headache. 2015;55(2):301–9.

    Article  PubMed  Google Scholar 

  56. Lea R, Colson N, Quinlan S, Macmillan J, Griffiths L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet Genomics. 2009;19(6):422–8.

    Article  CAS  PubMed  Google Scholar 

  57. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25(5):446–52.

    Article  PubMed  Google Scholar 

  58. Ali AM, Awad TG, Al-Adl NM. Efficacy of combined topiramate/thioctic acid therapy in migraine prophylaxis. Saudi Pharm J. 2010;18(4):239–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Magis D, Ambrosini A, Sandor P, Jacquy J, Laloux P, Schoenen J. A randomized double-blind placebo-controlled trial of thioctic acid in migrainoe prophylaxis. Headache. 2007;47(1):52–7.

    Article  PubMed  Google Scholar 

  60. Ramsden CE, Faurot KR, Zamora D, Suchindran CM, Macintosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013;154(11):2441–51.

    Article  CAS  PubMed  Google Scholar 

  61. Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay JM, et al. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia. 2001;21(8):818–22.

    Article  CAS  PubMed  Google Scholar 

  62. Ramsden CE, Mann JD, Faurot KR, Lynch C, Imam ST, MacIntosh BA, et al. Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial. Trials. 2011;12:97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, et al. Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci Official J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2009;30(Suppl 1):S121–4.

    Google Scholar 

  64. Allais G, D’Andrea G, Maggio M, Benedetto C. The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial. Neurol Sci Official J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2013;34(Suppl 1):S161–3.

    Google Scholar 

  65. Usai S, Grazzi L, Bussone G. Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up. Neurol Sci Official J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2011;32(Suppl 1):S197–9.

    Google Scholar 

  66. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490–502.

    Article  CAS  PubMed  Google Scholar 

  67. Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother. 2002;56(6):283–8.

    Article  CAS  PubMed  Google Scholar 

  68. Rhyne DN, Anderson SL, Gedde M, Borgelt LM. Effects of medical marijuana on migraine headache frequency in an adult population. Pharmacotherapy. 2016;36(5):505–10.

    Article  CAS  PubMed  Google Scholar 

  69. Russo E. Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain. 1998;76(1–2):3–8.

    Article  CAS  PubMed  Google Scholar 

  70. McGeeney BE. Cannabinoids and hallucinogens for headache. Headache. 2013;53(3):447–58.

    Article  PubMed  Google Scholar 

  71. Baron EP. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it’s been. Headache. 2015;55(6):885–916.

    Article  PubMed  Google Scholar 

  72. Mikuriya TH. Chronic migraine headache: Five cases successfully treated with marinol and/or illicit cannabis. 1991. Available from http://druglibrary.org/schaffer/hemp/migrn1.htm

  73. Prousky J, Seely D. The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature. Nutr J. 2005;4:3.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Velling DA, Dodick DW, Muir JJ. Sustained-release niacin for prevention of migraine headache. Mayo Clin Proc. 2003;78(6):770–1.

    Article  PubMed  Google Scholar 

  75. Evans EW, Lipton RB, Peterlin BL, Raynor HA, Thomas JG, O’Leary KC, et al. Dietary intake patterns and diet quality in a nationally representative sample of women with and without severe headache or migraine. Headache. 2015;55(4):550–61.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am. 2001;85(4):911–41.

    Article  CAS  PubMed  Google Scholar 

  77. Bunner AE, Agarwal U, Gonzales JF, Valente F, Barnard ND. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain. 2014;15:69.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Rockett FC, de Oliveira VR, Castro K, Perla Ada S, Perry ID. Dietary aspects of migraine trigger factors. Nutr Rev. 2012;70(6):337–56.

    Article  PubMed  Google Scholar 

  79. Ferrara LA, Pacioni D, Di Fronzo V, Russo BF, Speranza E, Carlino V, et al. Low-lipid diet reduces frequency and severity of acute migraine attacks. Nutr Metab Cardiovasc Dis NMCD. 2015;25(4):370–5.

    Article  CAS  PubMed  Google Scholar 

  80. Peterlin BL, Rosso AL, Williams MA, Rosenberg JR, Haythornthwaite JA, Merikangas KR, et al. Episodic migraine and obesity and the influence of age, race, and sex. Neurology. 2013;81(15):1314–21.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27(5):394–402.

    Article  CAS  PubMed  Google Scholar 

  82. Wober C, Holzhammer J, Zeitlhofer J, Wessely P, Wober-Bingol C. Trigger factors of migraine and tension-type headache: experience and knowledge of the patients. J Headache Pain. 2006;7(4):188–95.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Peris F, Donoghue S, Torres F, Mian A, Wober C. Towards improved migraine management: determining potential trigger factors in individual patients. Cephalalgia. 2016.

    Google Scholar 

  84. Carod-Artal FJ. Tackling chronic migraine: current perspectives. J Pain Res. 2014;7:185–94.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Baillie LE, Gabriele JM, Penzien DB. A systematic review of behavioral headache interventions with an aerobic exercise component. Headache. 2014;54(1):40–53.

    Article  PubMed  Google Scholar 

  86. Koseoglu E, Yetkin MF, Ugur F, Bilgen M. The role of exercise in migraine treatment. J Sports Med Phys Fitness. 2015;55(9):1029–36.

    CAS  PubMed  Google Scholar 

  87. Lambert RW Jr, Burnet DL. Prevention of exercise induced migraine by quantitative warm-up. Headache. 1985;25(6):317–9.

    Article  PubMed  Google Scholar 

  88. Domingues RB, Teixeira AL, Domingues SA. Physical practice is associated with less functional disability in medical students with migraine. Arq Neuropsiquiatr. 2011;69(1):39–43.

    Article  PubMed  Google Scholar 

  89. Calhoun AH, Ford S, Millen C, Finkel AG, Truong Y, Nie Y. The prevalence of neck pain in migraine. Headache. 2010;50(8):1273–7.

    Article  PubMed  Google Scholar 

  90. Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum (Minneapolis, Minn). 2012;18(4):796–806.

    Google Scholar 

  91. Trinh KV, Graham N, Gross AR, Goldsmith CH, Wang E, Cameron ID, et al. Acupuncture for neck disorders. Cochrane Database Syst Rev. 2006;3:CD004870.

    Google Scholar 

  92. Furlan AD, van Tulder M, Cherkin D, Tsukayama H, Lao L, Koes B, et al. Acupuncture and dry-needling for low back pain: an updated systematic review within the framework of the cochrane collaboration. Spine (Phila Pa 1976). 2005;30(8):944–63.

    Google Scholar 

  93. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;(1):CD001218.

    Google Scholar 

  94. Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Shin BC, et al. Acupuncture for the prevention of tension-type headache. Cochrane Database Syst Rev. 2016;4:CD007587.

    Google Scholar 

  95. Manheimer E, Cheng K, Linde K, Lao L, Yoo J, Wieland S, et al. Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev. 2010;(1):CD001977.

    Google Scholar 

  96. Meissner K, Fassler M, Rucker G, Kleijnen J, Hrobjartsson A, Schneider A, et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med. 2013;173(21):1941–51.

    Article  PubMed  Google Scholar 

  97. Li K, Zhang Y, Ning Y, Zhang H, Liu H, Fu C, et al. The effects of acupuncture treatment on the right frontoparietal network in migraine without aura patients. J Headache Pain. 2015;16:518.

    Article  PubMed  Google Scholar 

  98. Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ. 2004;328(7442):747.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Facco E, Liguori A, Petti F, Fauci AJ, Cavallin F, Zanette G. Acupuncture versus valproic acid in the prophylaxis of migraine without aura: a prospective controlled study. Minerva Anestesiol. 2013;79(6):634–42.

    CAS  PubMed  Google Scholar 

  100. Yang CP, Chang MH, Liu PE, Li TC, Hsieh CL, Hwang KL, et al. Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial. Cephalalgia. 2011;31(15):1510–21.

    Article  PubMed  Google Scholar 

  101. Streng A, Linde K, Hoppe A, Pfaffenrath V, Hammes M, Wagenpfeil S, et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache. 2006;46(10):1492–502.

    Article  PubMed  Google Scholar 

  102. Allais G, De Lorenzo C, Quirico PE, Airola G, Tolardo G, Mana O, et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache. 2002;42(9):855–61.

    Article  PubMed  Google Scholar 

  103. Parker GB, Tupling H, Pryor DS. A controlled trial of cervical manipulation of migraine. Aust NZ J Med. 1978;8(6):589–93.

    Article  CAS  Google Scholar 

  104. Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. J Manipulative Physiol Ther. 1998;21(8):511–9.

    CAS  PubMed  Google Scholar 

  105. Tuchin PJ, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther. 2000;23(2):91–5.

    Article  CAS  PubMed  Google Scholar 

  106. Hernandez-reif M, Dieter J, Field T, Swerdlow B, Diego M. Migraine headaches are reduced by massage therapy. Int J Neurosci. 1998;96(1–2):1–11.

    Article  Google Scholar 

  107. Lawler SP, Cameron LD. A randomized, controlled trial of massage therapy as a treatment for migraine. Ann Behav Med. 2006;32(1):50–9.

    Article  PubMed  Google Scholar 

  108. Robbins MS, Kuruvilla D, Blumenfeld A, Lt Charleston, Sorrell M, Robertson CE, et al. Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache. 2014;54(9):1441–59.

    Article  PubMed  Google Scholar 

  109. Garcia-Leiva JM, Hidalgo J, Rico-Villademoros F, Moreno V, Calandre EP. Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine. Pain Med. 2007;8(1):65–70.

    Article  PubMed  Google Scholar 

  110. Cuadrado ML, Aledo-Serrano A, Navarro P, Lopez-Ruiz P, Fernandez-de-Las-Penas C, Gonzalez-Suarez I, et al. Short-term effects of greater occipital nerve blocks in chronic migraine: a double-blind, randomised, placebo-controlled clinical trial. Cephalalgia. 2016 Jun 12. pii: 0333102416655159. [Epub ahead of print].

    Google Scholar 

  111. Dilli E, Halker R, Vargas B, Hentz J, Radam T, Rogers R, et al. Occipital nerve block for the short-term preventive treatment of migraine: a randomized, double-blinded, placebo-controlled study. Cephalalgia. 2015;35(11):959–68.

    Article  PubMed  Google Scholar 

  112. Sierpina V, Astin J, Giordano J. Mind-body therapies for headache. Am Fam Physician. 2007;76(10):1518–22.

    PubMed  Google Scholar 

  113. Nestoriuc Y, Martin A, Rief W, Andrasik F. Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2008;33(3):125–40.

    Article  PubMed  Google Scholar 

  114. Association for Applied P, Biofeedback. Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological interventions. Appl Psychophysiol Biofeedback. 2002;27(4):273–81.

    Article  Google Scholar 

  115. Anderson JA, Basker MA, Dalton R. Migraine and hypnotherapy. Int J Clin Exp Hypn. 1975;23(1):48–58.

    Article  CAS  PubMed  Google Scholar 

  116. Bennett MH, French C, Schnabel A, Wasiak J, Kranke P, Weibel S. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database Syst Rev. 2015;(12):CD005219.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PGY III Otolaryngology—Head and Neck Surgery, NewYork Presbyterian Hospital, New York, NY, USA

    Jiahui Lin

  2. Otolaryngology, The Blum Center for Health, 34 Rye Ridge Plaza, Rye Brook, 10573, New York, United States

    Sezelle Gereau Haddon

  3. Otolaryngology, The Mount Sinai Hospital, New York, NY, USA

    Sezelle Gereau Haddon

Authors
  1. Jiahui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sezelle Gereau Haddon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sezelle Gereau Haddon .

Editor information

Editors and Affiliations

  1. E.N.T. & Allergy Health Services , North Olmsted, Ohio, USA

    Mark E. Mehle

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Lin, J., Gereau Haddon, S. (2017). Adjunctive and Integrative Therapy in Migraine Management. In: Mehle, M. (eds) Sinus Headache, Migraine, and the Otolaryngologist. Springer, Cham. https://doi.org/10.1007/978-3-319-50376-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-50376-9_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-50375-2

  • Online ISBN: 978-3-319-50376-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation